Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV-infected people from the French Dat'AIDS cohort: A propensity score-matched analysis.

Laurent HocquelouxAmélie MenardCédric ArvieuxVéronique JolyAgathe BeckerAntoine ChéretClaudine DuvivierAndré CabiéCyrille DelpierreClotilde Allavenanull null

Published in: HIV medicine (2023)

Although modest, there is a significant weight gain following the substitution of TDF by TAF. This should be anticipated in certain at-risk populations.

Keyphrases

weight gain
antiretroviral therapy
hiv infected
body mass index
birth weight
human immunodeficiency virus
weight loss
hepatitis c virus
data analysis